Kwarlay.com

Navigating the News Maze with Clarity

Medicine

Sage and Biogen Halt Phase II Study After Novel Drug Shows No Significant Improvement in Treating Essential Tremor

admin July 25, 2024

Moving forward, Sage Therapeutics and Biogen intend to cease further clinical development of SAGE-324 for essential tremor.

LEAVE A RESPONSE Cancel reply

admin

Medicine

Asia Embracing New Technologies for Better Healthcare

admin August 13, 2024

Medicine

FDA Approves New Drug Application for Shorla Oncology’s Tepylute, a Ready-to-Dilute Formulation for the Treatment of Breast and Ovarian Cancer

admin July 2, 2024

Medicine

The Evolving Role of PBMs: An Interview with Bill Roth, General Manager, Managing Partner, Blue Fin Group

admin January 22, 2024

Medicine

CT-996 Demonstrates Significant Weight Loss in Patients with Obesity and Type 2 Diabetes

admin July 19, 2024